Involvement of Arginine Vasopressin and V1b Receptor in Alcohol Drinking in Sardinian Alcohol-Preferring Rats: VASOPRESSIN AND V1b IN ALCOHOL DRINKING

AChE-stained horizontal sections of the rat brain in stereotaxic coordinates

Paxinos, G., WATSON, C. R. R., & Emson, P. C. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90021-7 · Cited by 4,501 · see citing works

Oxytocin, vasopressin, and the neurogenetics of sociality

Donaldson, Z. R., & Young, L. J. (2008) · Science · doi:10.1126/science.1158668 · Cited by 1,645 · see citing works

The Challenge of Translation in Social Neuroscience: A Review of Oxytocin, Vasopressin, and Affiliative Behavior

Insel, T. R. (2010) · Neuron · doi:10.1016/j.neuron.2010.03.005 · Cited by 1,044 · see citing works

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V _1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Griebel, G., Simiand, J., Serradeil-Le Gal, C., Wagnon, J., Pascal, M., Scatton, B., Maffrand, J.-P., & Soubrié, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092012099 · Cited by 471 · see citing works

Extrapituitary expression of the rat V1b vasopressin receptor gene.

Lolait, S. J., O’Carroll, A., Mahan, L. C., Felder, C. C., Button, D. C., Young, W. S., Mezey, É., & Brownstein, M. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6783 · Cited by 337 · see citing works

Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine

van Ree, J. M., Gerrits, M. A. F. M., & Vanderschuren, L. J. M. J. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01405-4 · Cited by 300 · see citing works

Immunohistochemical Localization of the Vasopressin V1b Receptor in the Rat Brain and Pituitary Gland: Anatomical Support for Its Involvement in the Central Effects of Vasopressin

Hernando, F., Schoots, O., Lolait, S. J., & Burbach, J. P. H. (2001) · Endocrinology · doi:10.1210/endo.142.4.8067 · Cited by 275 · see citing works

Chronic ethanol ingestion decreases vasopressin mRNA in hypothalamic and extrahypothalamic nuclei of mouse brain

Gulya, K., Dave, J. R., & Hoffman, P. L. (1991) · Brain Research · doi:10.1016/0006-8993(91)90125-f · Cited by 265 · see citing works

Alterations in Central Neuropeptide Expression, Release, and Receptor Binding in Rats Bred for High Anxiety: Critical Role of Vasopressin

Wigger, A., Sánchez, M. M., Mathys, K. C., Ebner, K., Frank, E., Liu, D., Kresse, A. E., Neumann, I. D., Holsboer, F., Plotsky, P. M., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300290 · Cited by 263 · see citing works

Sardinian alcohol-preferring rats: A genetic animal model of anxiety

Colombo, G., Agabio, R., Lobina, C., Reali, R., Zocchi, A., Fadda, F., & GESSA, G. L. (1995) · Physiology & Behavior · doi:10.1016/0031-9384(94)00382-f · Cited by 197 · see citing works

Dissociation of the behavioural and endocrine effects of lysine vasopressin by tryptic digestion

de Wied, D., Greven, H. M., LANDE, S., & Witter, A. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb09582.x · Cited by 166 · see citing works

REVIEW: Phenotypic characterization of genetically selected Sardinian alcohol‐preferring (sP) and ‐non‐preferring (sNP) rats

Colombo, G., Lobina, C., Carai, M. A. M., et al. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00031.x · Cited by 160 · see citing works

Loss of vasopressin-immunoreactive neurons in alcoholics is dose-related and time-dependent

Harding, A., Halliday, G. M., Ng, J. L. F., Harper, C., & Kril, J. J. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00577-3 · Cited by 143 · see citing works

Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal

Zhou, Y., Bendor, J., Hofmann, L., Randesi, M., Ho, A., & Kreek, M. J. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06960 · Cited by 130 · see citing works

Forced swimming triggers vasopressin release within the amygdala to modulate stress‐coping strategies in rats

Ebner, K., Wotjak, C. T., Landgraf, R., & Engelmann, M. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01869.x · Cited by 104 · see citing works

Prolonged alcohol intake leads to irreversible loss of vasopressin and oxytocin neurons in the paraventricular nucleus of the hypothalamus

Silva, S. M., Madeira, M. D., Ruela, C., & Paula-Barbosa, M. M. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03261-9 · Cited by 98 · see citing works

Functional and Pharmacological Characterization of the First Specific Agonist and Antagonist for the V1b Receptor in Mammals

Claudine, S.-L. G., Derick, S., Brossard, G., Maurice, M., Simiand, J., Rolf, G., Griebel, G., & Guillon, G. (2003) · Stress · doi:10.1080/1025389032000114524 · Cited by 92 · see citing works

Antidepressant-like effect of ethanol revealed in the forced swimming test in Sardinian alcohol-preferring rats

Ciccocioppo, R., Panocka, I., Froldi, R., et al. (1999) · Psychopharmacology · doi:10.1007/s002130050988 · Cited by 91 · see citing works

Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats

Salomé, N., Stemmelin, J., Cohen, C., & Griebel, G. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0424-1 · Cited by 89 · see citing works

Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin

Zhou, Y., Leri, F., Cummins, E., Hoeschele, M., & Kreek, M. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301419 · Cited by 89 · see citing works

Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression

Hodgson, R. A., Higgins, G. A., Guthrie, D. H., Lu, S. X., Pond, A. J., Mullins, D. E., Guzzi, M. F., Parker, E. M., & Varty, G. B. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.12.021 · Cited by 82 · see citing works

Altered Amygdalar CRF Release and Increased Anxiety-Like Behavior in Sardinian Alcohol-Preferring Rats: A Microdialysis and Behavioral Study

Richter, R. M., Zorrilla, E. P., Basso, A. M., Koob, G. F., & Weiss, F. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb01979.x · Cited by 82 · see citing works

Effects of cocaine on the contents of neurohypophyseal hormones in the plasma and in different brain structures in rats

Sarnyai, Z., Vecsernyés, M., Laczi, F., Bíró, É., Szabó, G., & Kovács, G. L. (1992) · Neuropeptides · doi:10.1016/0143-4179(92)90006-i · Cited by 66 · see citing works

Heroin self-administration is under control of vasopressin

van Ree, J. M., & de Wied, D. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90511-2 · Cited by 65 · see citing works

Expression of Cytoplasmic and Nuclear Vasopressin RNA Following Castration and Testosterone Replacement: Evidence for Transcriptional Regulation

Szot, P., & Dorsa, D. M. (1994) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1994.1001 · Cited by 58 · see citing works

Antidepressant-like effects of the vasopressin V1b receptor antagonist SSR149415 in the Flinders Sensitive Line rat

Overstreet, D. H., & Griebel, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.07.021 · Cited by 58 · see citing works

Alcohol stimulates motor activity in selectively bred Sardinian alcohol-preferring (sP), but not in Sardinian alcohol-nonpreferring (sNP), rats

Agabio, R., Carai, M. A. M., Lobina, C., Pani, M., Reali, R., Vacca, G., Gessa, G. L., & Colombo, G. (2001) · Alcohol · doi:10.1016/s0741-8329(00)00144-0 · Cited by 57 · see citing works

Lower risk taking and exploratory behavior in alcohol-preferring sP rats than in alcohol non-preferring sNP rats in the multivariate concentric square field™ (MCSF) test

Roman, E., & Colombo, G. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.08.020 · Cited by 50 · see citing works

Hypothalamic vasopressin mRNA levels in mice are decreased after chronic ethanol ingestion

Ishizawa, H., Dave, J. R., Liu, L.-I., Tabakoff, B., & Hoffman, P. L. (1990) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(90)90015-p · Cited by 43 · see citing works

Amygdalar vasopressin mRNA increases in acute cocaine withdrawal: Evidence for opioid receptor modulation

Zhou, Y., Bendor, J., Yuferov, V. P., Schlussman, S. D., Ho, A., & Kreek, M. J. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.032 · Cited by 41 · see citing works

The acute intoxicating effects of ethanol are not dependent on the vasopressin 1a or 1b receptors

Caldwell, H. K., Stewart, J., Wiedholz, L. M., Millstein, R. A., Iacangelo, A. L., Holmes, A., Young, W. S., & Wersinger, S. R. (2006) · Neuropeptides · doi:10.1016/j.npep.2006.08.001 · Cited by 39 · see citing works

Genetic Factors Involved in the Effects of Developmental Low-Level Alcohol Induced Behavioral Alterations in Rats

Cagiano, R. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00306-2 · Cited by 30 · see citing works

Arginine vasopressin gene expression changes within the nucleus accumbens during environment elicited cocaine-conditioned response in rats

Rodríguez-Borrero, E., Rivera-Escalera, F., Candelas, F., Montalvo, J. G., Muñoz-Miranda, W. J., Walker, J. R., & Maldonado-Vlaar, C. S. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.040 · Cited by 30 · see citing works

Alcohol preference in mice lacking the Avpr1a vasopressin receptor

Sanbe, A., Takagi, N., Fujiwara, Y., Yamauchi, J., Endo, T., Mizutani, R., Takeo, S., Tsujimoto, G., & Tanoue, A. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00708.2007 · Cited by 27 · see citing works

More Vasopressin mRNA in the Paraventricular Hypothalamic Nucleus of Alcohol‐Preferring Rats and High Alcohol‐Drinking Rats Selectively Bred for High Alcohol Preference

Hwang, B. H., Froehlich, J. C., Hwang, W. S., Lumeng, L., & Li, T. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb04309.x · Cited by 26 · see citing works

Sardinian alcohol-preferring and non-preferring rats show different reactivity to aversive stimuli and a similar response to a natural reward

Leggio, B., Masi, F., Grappi, S., et al. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02533-2 · Cited by 26 · see citing works

Vasopressin and ethanol preference. I. Effects of vasopressin and the fragment DGAVP on altered ethanol preference in Brattleboro diabetes insipidus rats

Rigter, H., & Crabbe, J. C. (1985) · Peptides · doi:10.1016/0196-9781(85)90170-6 · Cited by 23 · see citing works

Involvement of vasopressin V1b receptor in anti-anxiety action of SSRI and SNRI in mice

Ishizuka, Y., Abe, H., Tanoue, A., Kannan, H., & Ishida, Y. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.11.004 · Cited by 17 · see citing works

The Effect of Desglycinamide‐(ARG8)‐Vasopressin (DGAVP) on the Acquisition of Free‐Choice Alcohol Drinking in Rhesus Monkeys

Kornet, M., Goosen, C., Ribbens, L. G., & van Ree, J. M. (1991) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1991.tb00520.x · Cited by 8 · see citing works

Distribution of oxytocin- and vasopressin-binding sites in the rat extended amygdala: a histoautoradiographic study

Veinante, P., & Freund-Mercier, M.-J. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970707)383:3

Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development

Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337 · see citing works

Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder

Burnette, E. M., Nieto, S. J., Grodin, E. N., Meredith, L. R., Hurley, B., Miotto, K., Gillis, A. J., & Ray, L. A. (2022) · Drugs · doi:10.1007/s40265-021-01670-3 · Cited by 169 · see citing works

Oxytocin blocks enhanced motivation for alcohol in alcohol dependence and blocks alcohol effects on GABAergic transmission in the central amygdala

Tunstall, B. J., Kirson, D., Zallar, L. J., McConnell, S. A., Vendruscolo, J. C. M., Ho, C. P., Oleata, C. S., Khom, S., Manning, M., Lee, M. R., et al. (2019) · PLOS Biology · doi:10.1371/journal.pbio.2006421 · Cited by 104 · see citing works

Oxytocin reduces ethanol self-administration in mice

King, C. E., Griffin, W. C., Luderman, L. N., Kates, M. M., McGinty, J. F., & Becker, H. C. (2017) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13359 · Cited by 89 · see citing works

A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence

for the National Institute on Alcohol Abuse and Alcoholism Clinical Investigations Group (NCIG) Study Group, Ryan, M. L., Falk, D. E., Fertig, J. B., Rendenbach-Mueller, B., Katz, D. A., Tracy, K. A., Strain, E. C., Dunn, K. E., Kampman, K., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.214 · Cited by 72 · see citing works

Oxytocin and vasopressin: signalling, behavioural modulation and potential therapeutic effects

Rae, M., Lemos Duarte, M., Gomes, I., Camarini, R., & Devi, L. A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15481 · Cited by 72 · see citing works

Vasopressin V1B receptor antagonists as potential antidepressants

Chaki, S. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab013 · Cited by 34 · see citing works

Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review

Fischler, P. V., Soyka, M., Seifritz, E., & Mutschler, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.927703 · Cited by 34 · see citing works

Vascular vasopressin receptors

Fox, A. W. (1988) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(88)90121-8 · Cited by 38 · see citing works

Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms

Andrés, M., Peña, A., Derick, S., Raufaste, D., Trojnar, J., Wiśniewski, K., Trueba, M., Gal, C. S., & Guillon, G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.026 · Cited by 13 · see citing works

Reduced contractile sensitivity and vasopressin receptor affinity in DOCA-salt hypertension

Bockman, C. S., Jeffries, W. B., Pettinger, W. A., et al. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.262.6.h1752 · Cited by 16 · see citing works

Vasopressin V2 Receptor Binding Is Down-Regulated during Renal Escape from Vasopressin-Induced Antidiuresis

Tian, Y., Sandberg, K. L., Murase, T., Baker, E. A., Speth, R. C., & Verbalis, J. G. (2000) · Endocrinology · doi:10.1210/endo.141.1.7256 · Cited by 80 · see citing works

Central effects of vasopressin and 1-desamino-8-d-arginine vasopressin (DDAVP) on interleukin-1 fever in the rat

NAYLOR, A. M., Gubitz, G., Dinarello, C. A., et al. (1987) · Brain Research · doi:10.1016/0006-8993(87)91179-6 · Cited by 23 · see citing works